Ludi Yang

949 total citations
40 papers, 636 citations indexed

About

Ludi Yang is a scholar working on Oncology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Ludi Yang has authored 40 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Molecular Biology and 10 papers in Ophthalmology. Recurrent topics in Ludi Yang's work include Ocular Oncology and Treatments (10 papers), Epigenetics and DNA Methylation (6 papers) and Ubiquitin and proteasome pathways (5 papers). Ludi Yang is often cited by papers focused on Ocular Oncology and Treatments (10 papers), Epigenetics and DNA Methylation (6 papers) and Ubiquitin and proteasome pathways (5 papers). Ludi Yang collaborates with scholars based in China, United States and Australia. Ludi Yang's co-authors include Xianqun Fan, Peiwei Chai, Jie Yu, Shengfang Ge, Xiang Gu, Ai Zhuang, Jing Ruan, Renbing Jia, Huaizhi Wang and Ruobing Jia and has published in prestigious journals such as Nucleic Acids Research, ACS Nano and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Ludi Yang

35 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludi Yang China 14 339 243 232 80 63 40 636
Lijun Mao China 14 342 1.0× 184 0.8× 103 0.4× 84 1.1× 71 1.1× 36 608
Qunxing Li China 15 464 1.4× 281 1.2× 385 1.7× 195 2.4× 104 1.7× 30 925
Xiujin Ye China 16 326 1.0× 253 1.0× 103 0.4× 236 3.0× 65 1.0× 94 984
James Monkman Australia 15 301 0.9× 357 1.5× 180 0.8× 208 2.6× 108 1.7× 41 770
Maria Chiara Scaini Italy 11 286 0.8× 252 1.0× 131 0.6× 24 0.3× 67 1.1× 21 477
Laure Vincent France 17 439 1.3× 179 0.7× 93 0.4× 66 0.8× 32 0.5× 58 802
Hongxia Li China 14 337 1.0× 126 0.5× 247 1.1× 62 0.8× 64 1.0× 39 575
Abdul Rouf Banday United States 10 263 0.8× 84 0.3× 104 0.4× 82 1.0× 32 0.5× 30 530
Gaoxiang Wang China 13 162 0.5× 148 0.6× 52 0.2× 68 0.8× 70 1.1× 64 442
Vito Alessandro Lasorsa Italy 14 286 0.8× 113 0.5× 230 1.0× 38 0.5× 35 0.6× 36 546

Countries citing papers authored by Ludi Yang

Since Specialization
Citations

This map shows the geographic impact of Ludi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludi Yang more than expected).

Fields of papers citing papers by Ludi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludi Yang. The network helps show where Ludi Yang may publish in the future.

Co-authorship network of co-authors of Ludi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ludi Yang. A scholar is included among the top collaborators of Ludi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludi Yang. Ludi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoran, Tongxin Ge, Shaoyun Wang, et al.. (2025). Epigenetic reprogramming holds promise in enhancing anti-tumor efficacy of CAR T cell therapy. Biotechnology Advances. 83. 108649–108649.
2.
3.
Cui, Ran, Gaoming Wang, Fuguo Liu, et al.. (2025). Neurturin-induced activation of GFRA2-RET axis potentiates pancreatic cancer glycolysis via phosphorylated hexokinase 2. Cancer Letters. 621. 217583–217583.
4.
Lin, Li, Yan Liu, Ludi Yang, et al.. (2024). Single-Cell Transcriptomic Sequencing Reveals Tissue Architecture and Deciphers Pathological Reprogramming During Retinal Ischemia in Macaca fascicularis. Investigative Ophthalmology & Visual Science. 65(1). 27–27. 5 indexed citations
5.
Yang, Ludi, Gaoming Wang, Hao Tian, et al.. (2024). RBMS1 reflects a distinct microenvironment and promotes tumor progression in ocular melanoma. Experimental Eye Research. 246. 109990–109990. 1 indexed citations
6.
Gu, Xiang, Ai Zhuang, Jie Yu, et al.. (2023). Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A. Nucleic Acids Research. 52(5). 2273–2289. 80 indexed citations
7.
Yu, Jie, Ai Zhuang, Xiang Gu, et al.. (2023). Nuclear PD-L1 promotes EGR1-mediated angiogenesis and accelerates tumorigenesis. Cell Discovery. 9(1). 33–33. 59 indexed citations
8.
Luo, Yingxiu, Ludi Yang, Yiran Yao, et al.. (2023). Correlating somatic copy number alteration in aqueous humour cfDNA with chemotherapy history, eye salvage and pathological features in retinoblastoma. British Journal of Ophthalmology. 108(3). 449–456. 7 indexed citations
9.
Gu, Xiang, Jie Yu, Ludi Yang, et al.. (2022). Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma. Journal of Pharmaceutical Analysis. 13(1). 24–38. 8 indexed citations
10.
Yang, Ludi, et al.. (2022). Nerve Dependence in Colorectal Cancer. Frontiers in Cell and Developmental Biology. 10. 766653–766653. 13 indexed citations
11.
Xu, Wei, et al.. (2022). Publication trends of research on conjunctival melanoma during 1997–2022: A 25-year bibliometric study. Frontiers in Oncology. 12. 960494–960494. 3 indexed citations
12.
Yang, Ludi, Ruobing Jia, Tongxin Ge, et al.. (2022). Extrachromosomal circular DNA: biogenesis, structure, functions and diseases. Signal Transduction and Targeted Therapy. 7(1). 342–342. 56 indexed citations
13.
Wang, Gaoming, Ludi Yang, Yongkun Wang, et al.. (2022). Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer. Frontiers in Immunology. 13. 939836–939836. 2 indexed citations
14.
Chai, Peiwei, Ruobing Jia, Yongyun Li, et al.. (2021). Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Progress in Retinal and Eye Research. 89. 101030–101030. 34 indexed citations
15.
Yang, Ludi, Xiang Gu, Jie Yu, Shengfang Ge, & Xianqun Fan. (2021). Oncolytic Virotherapy: From Bench to Bedside. Frontiers in Cell and Developmental Biology. 9. 790150–790150. 43 indexed citations
16.
Wang, Xishu, et al.. (2021). Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 601668–601668. 23 indexed citations
17.
Gu, Jianyou, Junfeng Zhang, Xianxing Wang, et al.. (2021). TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway. Frontiers in Oncology. 11. 628353–628353. 14 indexed citations
18.
Wang, Gaoming, Ludi Yang, Miao Hu, et al.. (2021). Comprehensive Analysis of the Prognostic Significance of Hsa-miR-100-5p and Its Related Gene Signature in Stomach Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 736274–736274. 8 indexed citations
19.
Liu, Songsong, Junfeng Zhang, Liangyu Yin, et al.. (2020). The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion. Cell Death and Disease. 11(6). 412–412. 29 indexed citations
20.
Zhang, Junfeng, Wenjie Huang, Tian Tao, et al.. (2020). Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4+ T cells. Annals of Translational Medicine. 8(6). 279–279. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lijun Mao Breakdown of academic impact, for papers by Qunxing Li Breakdown of academic impact, for papers by Xiujin Ye Breakdown of academic impact, for papers by James Monkman Breakdown of academic impact, for papers by Maria Chiara Scaini Breakdown of academic impact, for papers by Laure Vincent Breakdown of academic impact, for papers by Hongxia Li Breakdown of academic impact, for papers by Abdul Rouf Banday Breakdown of academic impact, for papers by Gaoxiang Wang Breakdown of academic impact, for papers by Vito Alessandro Lasorsa
Rankless by CCL
2026